News and features

The Institute of Cancer Research, London, celebrated the opening of the new £20 million Centre for Cancer Imaging on its Sutton site this week. The state-of-the-art building is designed to drive collaboration between researchers from many different fields on pioneering approaches to cancer imaging.

Healthy cells actively collaborate with tumours by creating a mesh of collagen that encourages cancer cells to build new blood vessels, a new study shows.

A combination of two drugs delays progression of advanced, aggressive breast cancer by an average of nine months – working in all subsets of the most common type of breast cancer, research has shown.

A new imaging technique could allow doctors to assess accurately if cancer has spread into the bones of prostate cancer patients, and how severe it is.

Researchers are discovering biological markers that can predict the sensitivity of tumours to radiotherapy, with the potential to tailor dosing to individual patients, finds Liz Burtally.

A family of proteins known as 'ROCK' regulate the shape and movement of cells, and in doing so help to control tumour growth, a new study reveals.

In the last instalment of a three-part essay reflecting on five decades of cancer treatment advances, ICR CEO Professor Paul Workman explores the transition from classical chemotherapy drugs to new molecularly targeted treatments and immunotherapy, and discusses the attitudes and language used in the drive to defeat cancer.

Students from Wembley High Technology College visited The Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, to learn how they could become the cancer researchers of the future.

Breast cancers which are particularly complex and diverse, as judged by a test used in ecology to analyse species of animals and plants, are particularly likely to progress and lead to death, a new study shows.

Scientists have developed a new viral therapy that is capable of killing prostate cancer cells, and found it is even more effective when combined with a type of radiotherapy.

Scientists have developed a mathematical model that describes a key step in human cell division – and an important target for cancer treatment – in unprecedented detail.

In a special, three-part essay, ICR Chief Executive Professor Paul Workman reflects on five decades of advances in cancer treatment – inspired by The Death of Cancer, an account by the clinical research pioneer Vincent DeVita. In part two, he explores the huge political repercussions of those early breakthroughs in treatment.